ChulaCov19 COVID-19 vaccine Research Center

First lot of local ChulaCov19 vaccine produced

The first batch of ChulaCov19, the first messenger-RNA vaccine developed in Thailand, has been produced and is awaiting Food and Drug Administration (FDA) approval for the first two phases of human trials, a government spokesperson said on Saturday.

The first lot of the Covid-19 vaccine developed by Chulalongkorn University researchers was produced by Thailand-based BioNet-Asia Co Ltd. If all trial results meet the requirements, the vaccine is expected to be registered for use by the end of this year, deputy government spokeswoman Rachada Dhnadirek said.

Full story: Bangkok Post



The main purpose of Thailand News is to offer our readers all news from the most popular and trusted newspapers in Thailand & Asia in one place.

Get breaking news and the latest news headlines from Bangkok, Phuket, Pattaya, Chiang Mai, Northern Thailand, Isan, the insurgency-plagued South and Asia.

You May Also Like

More From Author

+ There are no comments

Add yours

Leave a Reply